Jeffrey H Lawson

Summary

Affiliation: Duke University Medical Center
Country: USA

Publications

  1. ncbi Relative purity of thrombin-based hemostatic agents used in surgery
    Jonathan G Schoenecker
    Department of Pathology, Duke University Medical Center, Durham, NC, USA
    J Am Coll Surg 197:580-90. 2003
  2. ncbi Antihuman factor V antibodies after use of relatively pure bovine thrombin
    Jeffrey H Lawson
    Department of Surgery, Duke University Medical Center, Durham, North Carolina 27710, USA
    Ann Thorac Surg 79:1037-8. 2005
  3. ncbi Use of autologous blood-derived endothelial progenitor cells at point-of-care to protect against implant thrombosis in a large animal model
    Alexandra E Jantzen
    Department of Biomedical Engineering, Duke University, 136 Hudson Hall, Box 90281, Durham, NC 27708, USA
    Biomaterials 32:8356-63. 2011
  4. ncbi Bovine thrombin: history, use, and risk in the surgical patient
    Diana L Diesen
    Department of Surgery, Duke University Medical Center, Durham, NC 27710, USA
    Vascular 16:S29-36. 2008
  5. ncbi Acute in-vivo evaluation of bleeding with Gelfoam plus saline and Gelfoam plus human thrombin using a liver square lesion model in swine
    George L Adams
    Department of Medicine, Duke University Medical Center, Durham, NC 27710, USA
    J Thromb Thrombolysis 28:1-5. 2009
  6. ncbi Coagulopathy and inflammation in neonatal heart surgery: mechanisms and strategies
    James Jaggers
    Department of Pediatric Cardiothoracic Surgery, Duke University Medical Center, Durham, North Carolina 27710, USA
    Ann Thorac Surg 81:S2360-6. 2006
  7. ncbi Review of the biology of bleeding and clotting in the surgical patient
    Hardean E Achneck
    Department of Surgery, Duke University Medical Center, Durham, NC 27710, USA
    Vascular 16:S6-13. 2008
  8. ncbi Effectiveness of Glycerol Mono-oleate as a Biosealant
    George L Adams
    Department of Medicine, Duke University Medical Center, Box 2622, Durham, NC, 27710, USA
    J Invasive Cardiol 20:29-34. 2008
  9. ncbi In vitro functional testing of endothelial progenitor cells that overexpress thrombomodulin
    John D Stroncek
    Department of Biomedical Engineering, Duke University, Durham, North Carolina 27708 0281, USA
    Tissue Eng Part A 17:2091-100. 2011
  10. ncbi Salvaging vascular access and treatment of severe limb edema: case reports on the novel use of the hemodialysis reliable outflow vascular access device
    Shawn M Gage
    Section of Vascular Surgery, Department of Surgery, Duke University Medical Center, Durham, NC 27710, USA
    Ann Vasc Surg 25:387.e1-5. 2011

Collaborators

Detail Information

Publications43

  1. ncbi Relative purity of thrombin-based hemostatic agents used in surgery
    Jonathan G Schoenecker
    Department of Pathology, Duke University Medical Center, Durham, NC, USA
    J Am Coll Surg 197:580-90. 2003
    ..The cross-reactivity of elicited antibovine thrombin antibodies indicates that if a patient has been sensitized to a bovine product, it is likely safer to use a human-derived product in lieu of a bovine product...
  2. ncbi Antihuman factor V antibodies after use of relatively pure bovine thrombin
    Jeffrey H Lawson
    Department of Surgery, Duke University Medical Center, Durham, North Carolina 27710, USA
    Ann Thorac Surg 79:1037-8. 2005
    ..This report calls into question the safety of even relatively pure bovine thrombin...
  3. ncbi Use of autologous blood-derived endothelial progenitor cells at point-of-care to protect against implant thrombosis in a large animal model
    Alexandra E Jantzen
    Department of Biomedical Engineering, Duke University, 136 Hudson Hall, Box 90281, Durham, NC 27708, USA
    Biomaterials 32:8356-63. 2011
    ..These results suggest that late outgrowth autologous EPCs represent a promising source of lining Ti implants to reduce thrombosis in vivo...
  4. ncbi Bovine thrombin: history, use, and risk in the surgical patient
    Diana L Diesen
    Department of Surgery, Duke University Medical Center, Durham, NC 27710, USA
    Vascular 16:S29-36. 2008
    ..Animal studies confirm these immunological responses seen in humans. With the available clinical and laboratory data, a less immunogenic yet biologically effective thrombin should be available for use in our surgical patients...
  5. ncbi Acute in-vivo evaluation of bleeding with Gelfoam plus saline and Gelfoam plus human thrombin using a liver square lesion model in swine
    George L Adams
    Department of Medicine, Duke University Medical Center, Durham, NC 27710, USA
    J Thromb Thrombolysis 28:1-5. 2009
    ..This study utilized a novel ordinal bleeding model to test whether a Gelfoam + human thrombin solution is superior at controlling bleeding when compared to Gelfoam + saline solution at different time intervals...
  6. ncbi Coagulopathy and inflammation in neonatal heart surgery: mechanisms and strategies
    James Jaggers
    Department of Pediatric Cardiothoracic Surgery, Duke University Medical Center, Durham, North Carolina 27710, USA
    Ann Thorac Surg 81:S2360-6. 2006
  7. ncbi Review of the biology of bleeding and clotting in the surgical patient
    Hardean E Achneck
    Department of Surgery, Duke University Medical Center, Durham, NC 27710, USA
    Vascular 16:S6-13. 2008
    ....
  8. ncbi Effectiveness of Glycerol Mono-oleate as a Biosealant
    George L Adams
    Department of Medicine, Duke University Medical Center, Box 2622, Durham, NC, 27710, USA
    J Invasive Cardiol 20:29-34. 2008
    ..We assessed whether GMO would: 1) achieve hemostasis more effectively than control when injected into a swine liver biopsy tract; and 2) inhibit common percutaneous procedure pathogens...
  9. ncbi In vitro functional testing of endothelial progenitor cells that overexpress thrombomodulin
    John D Stroncek
    Department of Biomedical Engineering, Duke University, Durham, North Carolina 27708 0281, USA
    Tissue Eng Part A 17:2091-100. 2011
    ..05). These data indicate that TM-overexpression has the potential to improve the antithrombotic performance of patient-derived EPCs for endothelialization applications...
  10. ncbi Salvaging vascular access and treatment of severe limb edema: case reports on the novel use of the hemodialysis reliable outflow vascular access device
    Shawn M Gage
    Section of Vascular Surgery, Department of Surgery, Duke University Medical Center, Durham, NC 27710, USA
    Ann Vasc Surg 25:387.e1-5. 2011
    ....
  11. ncbi The biocompatibility of titanium cardiovascular devices seeded with autologous blood-derived endothelial progenitor cells: EPC-seeded antithrombotic Ti implants
    Hardean E Achneck
    Department of Surgery, Division of General Surgery, Duke University Medical Center, DUMC Box 2622, Durham, NC 27710, USA
    Biomaterials 32:10-8. 2011
    ..Therefore EPCs may be used to seed cardiovascular devices prior to implantation to ameliorate platelet activation and thrombus formation...
  12. ncbi Readily available tissue-engineered vascular grafts
    Shannon L M Dahl
    Humacyte Inc, Durham, NC 27709, USA
    Sci Transl Med 3:68ra9. 2011
    ..Such tissue-engineered vascular grafts may provide a readily available option for patients without suitable autologous tissue or for those who are not candidates for synthetic grafts...
  13. ncbi Surgical aspects and biological considerations of arteriovenous fistula placement
    Hardean E Achneck
    Department of Surgery, Duke University Medical Center, Durham, North Carolina 27710, USA
    Semin Dial 23:25-33. 2010
    ..However, in some cases a surgical revision of the access site through patch angioplasty, a jump graft, and graft interposition is necessary to create a fistula which can be successfully used for hemodialysis...
  14. ncbi Application of energy-based technologies and topical hemostatic agents in the management of surgical hemostasis
    Bantayehu Sileshi
    Department of Surgery, Duke University Medical Center, Durham, NC 27710, USA
    Vascular 18:197-204. 2010
    ..Furthermore, the costs of the various methods are presented, allowing the provider to choose not only the most potent but also the most cost-effective treatment modality in each situation...
  15. ncbi Management of surgical hemostasis: topical agents
    Bantayehu Sileshi
    Department of Surgery, Duke University Medical Center, Durham, NC 27710, USA
    Vascular 16:S22-8. 2008
    ..In this article, we review the currently available topical hemostatic agents, compare their efficacy, and give general recommendations for their use in the operating room...
  16. ncbi Surgical excision of infected arteriovenous grafts: technique and review
    Eugene P Ceppa
    Department of Surgery, Duke University Medical Center, Durham, NC 27710, USA
    J Vasc Access 10:148-52. 2009
    ..Here we present five recent cases and describe our technique for total graft excision. We also review the literature and discuss the much debated role of partial, subtotal, and total graft excision...
  17. ncbi Reduction of vascular intimal-medial hyperplasia in polytetrafluoroethylene arteriovenous grafts via expression of an inhibitor of G protein signaling
    Ryan C Fields
    Department of Surgery, Duke University Medical Center, DUMC Box 2622, Room 481 MSRB, Research Drive, Durham, NC, 27710, USA
    Ann Vasc Surg 19:712-8. 2005
    ..The inhibition of G(betagamma) signaling reduces intimal-medial hyperplasia and prolongs graft patency in PTFE AV grafts. This represents a novel molecular therapeutic strategy for improving the patency of vascular access grafts...
  18. ncbi Gene therapy in tissue-engineered blood vessels
    Ryan C Fields
    Department of Surgery and Pathology, Duke University Medical Center, Durham, North Carolina 27710, USA
    Tissue Eng 9:1281-7. 2003
    ..This also provides the framework for testing an array of genes that may improve the function of engineered blood vessels after surgical implantation...
  19. ncbi Management of hemostasis in vascular surgery
    Brian R Untch
    Department of Surgery, Duke University Medical Center, Durham, NC 27710, USA
    Surgery 142:S26-33. 2007
    ..Topics related to preoperative evaluation, surgical technique, monitoring, and pharmacologic manipulation will be discussed...
  20. ncbi The balance of thrombosis and hemorrhage in surgery
    George L Adams
    Department of Medicine, Duke University Medical Center, Box 2622, MSRB, Research Drive, Durham, NC 27710, USA
    Hematol Oncol Clin North Am 21:13-24. 2007
    ..Additional research focused on improvement in screening tools, monitoring, and therapeutic regimens for surgical patients with a coagulopathy are warranted...
  21. ncbi An early study on the mechanisms that allow tissue-engineered vascular grafts to resist intimal hyperplasia
    Heather L Prichard
    Humacyte, Inc, Durham, NC 27709, USA
    J Cardiovasc Transl Res 4:674-82. 2011
    ..Our findings suggest that arteriovenous TEVGs develop only a mild form of venous intimal hyperplasia, which results from the typical hemodynamic changes that are associated with arteriovenous settings...
  22. ncbi A comprehensive review of topical hemostatic agents: efficacy and recommendations for use
    Hardean E Achneck
    Department of Surgery, Duke University Medical Center, Durham, NC 27710, USA
    Ann Surg 251:217-28. 2010
    ..Furthermore, wholesale acquisition prices for hospitals in the United States are provided to aid in cost analysis. We conclude with an expert opinion on which agent to use under different scenarios...
  23. ncbi The clinical use and immunologic impact of thrombin in surgery
    Jeffrey H Lawson
    Departments of Surgery and Pathology, Duke University Medical Center, Durham, North Carolina 27710, USA
    Semin Thromb Hemost 32:98-110. 2006
    ..If a nonimmunologic and effective thrombin were developed, one would expect it to be rapidly adopted by the clinical community...
  24. ncbi Autologous bone marrow mononuclear cell therapy is safe and promotes amputation-free survival in patients with critical limb ischemia
    Michael P Murphy
    Department of Surgery, Indiana University School of Medicine, Indianapolis, IN 46202 1228, USA
    J Vasc Surg 53:1565-74.e1. 2011
    ....
  25. ncbi Recent clinical and investigational applications of fibrin sealant in selected surgical specialties
    David M Albala
    Division of Urology, Department of Surgery, Duke University Medical Center, Durham, NC 27710, USA
    J Am Coll Surg 202:685-97. 2006
  26. ncbi Stem cell use in a patient with an ischemic foot ulcer: a case study
    Debra Kohlman-Trigoboff
    Duke University Medical Center, Durham, North Carolina, USA
    J Vasc Nurs 24:56-61. 2006
    ..The process of angiogenesis using EPCs will be examined discussing the screening criteria and possible adverse events. The patient's history and progress throughout the recovery period will be reviewed...
  27. ncbi Genomic modeling of atherosclerosis in peripheral arterial disease and its variant phenotype in patients with diabetes
    David C Evans
    Department of Surgery, Duke University Medical Center, Durham, NC 27710, USA
    Vascular 16:225-35. 2008
    ..Developing distinct genomic models of PAD will serve as the first step toward understanding the molecular and genetic basis of PAD and subsequent application of novel therapeutics to this condition...
  28. ncbi Challenges for providing effective hemostasis in surgery and trauma
    Jeffrey H Lawson
    Department of Surgery, Duke University Medical Center, Durham, NC, USA
    Semin Hematol 41:55-64. 2004
    ..However, many of these agents have not yet been tested in clinical trials and studies are urgently needed to determine efficacy, safety, optimal dosage and time of administration...
  29. ncbi Anticoagulation strategies for venous thromboembolism
    David Peterson
    Duke University, Durham, NC, USA
    Perspect Vasc Surg Endovasc Ther 21:125-32. 2009
    ..It results in more than 200 000 deaths per year and is thought to be the number one cause of preventable in-hospital deaths. This review presents the history, pathophysiology, diagnostic considerations, and treatment options for VTE...
  30. ncbi Regenerating titanium ventricular assist device surfaces after gold/palladium coating for scanning electron microscopy
    Hardean E Achneck
    Department of Surgery, Division of General Surgery, Duke University Medical Center, Durham, North Carolina 27710, USA
    Microsc Res Tech 73:71-6. 2010
    ..The protocol described herein is applicable to almost all titanium surfaces used in biomedical sciences and because of its short exposure time to aqua regia, will likely work for many titanium alloys as well...
  31. ncbi Antiphospholipid antibodies after surgical exposure to topical bovine thrombin
    Zuowei Su
    Department of Medicine, Division of Hematology, Duke University Medical Center, Durham, NC 27710, USA
    J Lab Clin Med 139:349-56. 2002
    ..Nevertheless, our findings support the recommendation that the clinical safety of these commonly used hemostatic agents should be reassessed...
  32. ncbi Congenital jugular vein phlebectasia: a case report and review of the literature
    John C Haney
    Division of Vascular Surgery, Department of Surgery, Duke University Medical Center, Durham, NC, USA
    Ann Vasc Surg 22:681-3. 2008
    ..Pertinent literature and relevant diagnostic and therapeutic modalities are reviewed. While conservative management is usually prescribed, ligation and resection may be performed safely when intervention is warranted...
  33. ncbi Analysis of infection risk following covered stent exclusion of pseudoaneurysms in prosthetic arteriovenous hemodialysis access grafts
    Charles Y Kim
    Division of Vascular and Interventional Radiology, Duke University Medical Center, Box 3808, Durham, NC 27710, USA
    J Vasc Interv Radiol 23:69-74. 2012
    ..To determine whether exclusion of pseudoaneurysms with the use of a covered stent in prosthetic arteriovenous (AV) hemodialysis access grafts impacts the incidence of eventual AV graft infection...
  34. ncbi Disseminated intravascular coagulation in association with pig-to-primate pulmonary xenotransplantation
    Jeffrey G Gaca
    Department of Surgery, Duke University Medical Center, Durham, NC 27710, USA
    Transplantation 73:1717-23. 2002
    ..Thus, the DIC in pulmonary xenotransplantation may represent a unique and/or accelerated version of the coagulopathy observed with renal and bone marrow xenotransplantation...
  35. ncbi Human arteries engineered in vitro
    J Andrew McKee
    Department of Anesthesiology and Department of Biomedical Engineering, Duke University Medical Center, Durham, NC 27710, USA
    EMBO Rep 4:633-8. 2003
    ..Importantly, using these non-neonatal SMCs, we were able to engineer mechanically robust human vessels, a crucial step towards creating arteries of clinical value for bypass surgery...
  36. ncbi Hypercoagulable states and antithrombotic strategies in recurrent vascular access site thrombosis
    Susan I O'Shea
    Department of Medicine, Duke University Medical Center, Durham, NC 27710, USA
    J Vasc Surg 38:541-8. 2003
    ..Prospective studies are needed to evaluate the role and safety of antithrombotic agents in improving vascular access graft patency...
  37. ncbi Giant cell arteritis manifesting as mesenteric ischemia
    David Clay Evans
    Department of Surgery, Duke University Medical Center, Durham, NC 27710, USA
    J Vasc Surg 42:1019-22. 2005
    ..Giant cell arteritis is a rare and easily overlooked cause of vascular insufficiency that can result in a devastating clinical outcome if not recognized before surgical therapy or other interventions are attempted...
  38. ncbi Fibrin sealant improves hemostasis in peripheral vascular surgery: a randomized prospective trial
    Worthington G Schenk
    Department of Surgery, University of Virginia, Charlottesville, VA 22908, USA
    Ann Surg 237:871-6; discussion 876. 2003
    ..Adverse events were comparable in all groups. There were no seroconversions. CONCLUSIONS: FS achieved more rapid hemostasis than traditional techniques in this peripheral vascular procedure. FS use appeared to be safe for this procedure...
  39. ncbi Design of the Dialysis Access Consortium (DAC) Aggrenox Prevention Of Access Stenosis Trial
    Bradley S Dixon
    Nephrology Division, Veterans Affairs Medical Center and University of Iowa School of Medicine, Iowa City 52242 1081, USA
    Clin Trials 2:400-12. 2005
    ..The Dialysis Access Consortium (DAC) Aggrenox Prevention of Access Stenosis Trial tests the hypothesis that Aggrenox (containing dipyridamole and aspirin) can prevent stenosis and prolong survival of arteriovenous grafts...
  40. ncbi Design of the Dialysis Access Consortium (DAC) Clopidogrel Prevention of Early AV Fistula Thrombosis Trial
    Laura M Dember
    Renal Section, Boston University School of Medicine, MA 02118 USA
    Clin Trials 2:413-22. 2005
    ..The autogenous arteriovenous fistula created by direct connection of native artery to vein is the recommended vascular access for hemodialysis. However, it fails frequently due to clotting after surgery...
  41. ncbi Adventitial endothelial implants reduce matrix metalloproteinase-2 expression and increase luminal diameter in porcine arteriovenous grafts
    Helen M Nugent
    Harvard MIT Division of Health Sciences and Technology, Massachusetts Institute of Technology, Cambridge, MA, USA
    J Vasc Surg 46:548-556. 2007
    ..In this study, we aimed to provide further insight into the mechanism of endothelial regulation of vascular remodeling and luminal narrowing in AVGs...
  42. ncbi Multicenter evaluation of the bovine mesenteric vein bioprostheses for hemodialysis access in patients with an earlier failed prosthetic graft
    Howard E Katzman
    Cedars Medical Center, Miami, FL, USA
    J Am Coll Surg 201:223-30. 2005
    ..These results suggest that MVB offers a safe alternative to patients who have a history of failing synthetic access grafts and may represent an option for extending vascular access to this patient population...
  43. ncbi The coagulopathy of trauma versus disseminated intravascular coagulation
    John R Hess
    Department of Pathology, University of Maryland Medical Center, Baltimore, 21201, USA
    J Trauma 60:S12-9. 2006
    ..The coagulopathy of trauma should be anticipated in massive transfusion situations. Early treatment with plasma can delay its onset. The underlying mechanisms should be confirmed with laboratory testing...